Delivery Order SPE2DB20D1100-SPE2DB25FZ89A

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,605.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of October 25, 2024. This award is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,902.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a completion date of November 29, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and does not have any...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,441.81 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award, valued at $1,944.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product. This is a Firm Fixed Price Delivery Order contract with a completion date of January 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,477.80, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 19, 2022. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,305.89 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $2,028.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for NOVOLOG 100 UNIT/ML VIAL 10ML, a medical commodity used in federal healthcare programs. The award has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.80 firm fixed-price delivery order contract provides for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $2,420.34 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML VIAL 10ML pharmaceutical products. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle...
This federal contract award, valued at $6,565.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 10ML VIAL 1S medical supplies, with a performance period ending on January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FZ89A
    Delivery Order

This federal contract award, valued at $5,920.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a completion date of January 3, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/3/25, 10:13 AM